ArticlePediatric nephrology (Berlin, Germany)2025

Low-dose obinutuzumab for steroid-dependent nephrotic syndrome complicated by recurrent rituximab-induced serum sickness and anti-rituximab antibodies.

Shuichiro Fujinaga et al.PubMed ↗Publisher ↗

No numbers read from the abstract.